Pharma Marketing Network

My post yesterday regarding PhRMA's response to my letter citing a violation of its DTC Guiding Principles by Sepracor (see "PhRMA's Response - PRwise,...

On May 3, 2006 I wrote to PhRMA's Office of Accountability complaining that Sepracor was "sneaking" in Lunesta "reminder ads" despite being a signatory...

Continuing my study of PR (Public Relations) as a "stealth" pharma marketing tool, I read the book "The Fall of Advertising & The Rise...

This question was explored by panelists partici-pating in this month's Pharma Marketing Roundtable conference call, which was focused on pharmaceutical industry support of CME.

This article summarizes several presentations made at a recent CBI Annual Forum on Field-Based Dissemination of Scientific Information held in Philadelphia. Experts speak candidly and openly about challenges faced by Medical Science Liaisons and how these challenges are being met by the industry.

This article reviews the physician meeting logistics and planning capabilities of Alliance Communications, which has worked with pharma companies and key opinion leaders since 1987.

This article reviews the ForMyDiet Platform, which provides valuable resources for customer acquisition, compliance, adherence, persistence and healthcare provider care.

Al and Laura Ries make several arguments in their book The Fall of Advertising & The Rise of PR to support their claim that PR builds brands whereas advertising merely serves to defend the brand. This article provides real world pharmaceutical examples in support of the Ries's claims.

This conference will focus on identifying suitable compounds and opportunities for repurposing.

Yesterday's post, "Marketing Disguised as PR", generated some interesting counterpoints and comments from friends in the blogosphere and on the PHARMA-MKTING discussion forum. Seems...